Saturday February 24th 2018

​Why Roche’s multiple sclerosis drug approval is bittersweet news for Biogen

The FDA ’s approval of Roche’s multiple sclerosis treatment Ocrevus late Tuesday could have significant consequences for Biogen, which now faces even stiffer competition in the MS market but will receive double-digit royalties on U.S. sales of the drug. The FDA announced Tuesday evening that it had app roved Ocrevus for the treatment of two forms of multiple sclerosis — relapsing and primary progressive — that together affect around 95 of all patients with the disease. There was previously… (Source: bizjournals.com Health Care:Physician Practices headlines)

Link:  

​Why Roche’s multiple sclerosis drug approval is bittersweet news for Biogen

Leave a Comment

More from category

Multiple sclerosis: Skin cells may help to repair nerve damage
Multiple sclerosis: Skin cells may help to repair nerve damage

Researchers could be on the verge of a new treatment for multiple sclerosis; they reveal how transplanting neural stem [Read More]

Medical News Today: Multiple sclerosis: Skin cells may help to repair nerve damage
Medical News Today: Multiple sclerosis: Skin cells may help to repair nerve damage

Researchers could be on the verge of a new treatment for multiple sclerosis; they reveal how transplanting neural stem [Read More]

Researchers discover how the body skillfully extinguishes inflammation
Researchers discover how the body skillfully extinguishes inflammation

Inflammation needs energy An important source for this energy is oxygen, which is indispensable for the cells of the [Read More]

MS patients who feel stigmatized more likely to suffer from depression
MS patients who feel stigmatized more likely to suffer from depression

People with Multiple Sclerosis -- MS -- who feel stigmatized are more likely to suffer from depression, according to [Read More]

Stigma increases risk of depression for people with Multiple Sclerosis
Stigma increases risk of depression for people with Multiple Sclerosis

(Penn State) People with Multiple Sclerosis -- MS -- who feel stigmatized are more likely to suffer from depression, [Read More]